Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years

L Beyer, H Stocker, D Rujescu… - Alzheimer's & …, 2023 - Wiley Online Library
Introduction Blood‐based biomarkers for Alzheimer's disease (AD) are urgently needed.
Here, four plasma biomarkers were measured at baseline in a community‐based cohort …

The search for a convenient procedure to detect one of the earliest signs of Alzheimer's disease: a systematic review of the prediction of brain amyloid status

MT Ashford, DP Veitch, J Neuhaus… - Alzheimer's & …, 2021 - Wiley Online Library
Introduction Convenient, cost‐effective tests for amyloid beta (Aβ) are needed to identify
those at higher risk for developing Alzheimer's disease (AD). This systematic review …

Early β‐amyloid accumulation in the brain is associated with peripheral T cell alterations

C Gericke, T Kirabali, R Flury, A Mallone… - Alzheimer's & …, 2023 - Wiley Online Library
INTRODUCTION Fast and minimally invasive approaches for early diagnosis of Alzheimer's
disease (AD) are highly anticipated. Evidence of adaptive immune cells responding to …

[HTML][HTML] MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons

H Xu, Q Qiu, P Hu, K Hoxha, E Jang, M O'Reilly… - Acta …, 2024 - Springer
Inclusions comprised of microtubule-associated protein tau (tau) are implicated in a group of
neurodegenerative diseases, collectively known as tauopathies, that include Alzheimer's …

[HTML][HTML] An Electrochemical Immunosensor with PEDOT: PSS/MWCNTs-COOH Nanocomposites as a Modified Working Electrode Material for Detecting Tau-441

H Ren, X Liu, S Wei, F Zhao, Z Chen, H Xiao - Chemosensors, 2023 - mdpi.com
The progression of Alzheimer's disease (AD) is positively correlated with the
phosphorylation damage of Tau-441 protein, which is the marker with the most potential for …

Early Β-Amyloid Accumulation in the Brain Is Associated With Blood T and B Cell Alterations

C Gericke, T Kirabali, R Flury, A Mallone… - Available at SSRN …, 2021 - papers.ssrn.com
Fast and minimally invasive approaches for early, preclinical diagnosis of
neurodegenerative Alzheimer's disease (AD) are highly anticipated. Evidence of adaptive …